Gonzalo Rodolfo Malca Garcia

Dr. Gonzalo Rodolfo Malca Garcia


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2010 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
Rainer W BussmannRainer W Bussmann
Rainer W Bussmann
GGGonzalo Rodolfo Malca Garcia
Gonzalo Rodolfo Malca Garcia
AGA. Glenn
A. Glenn
DSD. Sharon
D. Sharon
GCG. Chait
G. Chait
MBM. Benito
M. Benito

18 September 2020 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
OMObinna C. Mbachu
Obinna C. Mbachu
CHCaitlin Howell
Caitlin Howell
CSCharlotte Simmler
Charlotte Simmler
GGGonzalo Rodolfo Malca Garcia
Gonzalo Rodolfo Malca Garcia
KSKornelia J. Skowron
Kornelia J. Skowron
BDBirgit M. Dietz
Birgit M. Dietz

1 June 2019 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
GGGonzalo Rodolfo Malca Garcia
Gonzalo Rodolfo Malca Garcia
DZDaniel Zagal
Daniel Zagal
JGJames Graham
James Graham
DNDejan Nikolić
Dejan Nikolić
JFJ. Brent Friesen
J. Brent Friesen
GPGuido F. Pauli
Guido F. Pauli

1 November 2019 in Journal of Chromatography A
Verified
Journal Article
Closed access
GGGonzalo Rodolfo Malca Garcia
Gonzalo Rodolfo Malca Garcia
JFJ. Brent Friesen
J. Brent Friesen
YLYang Liu
Yang Liu
DNDejan Nikolić
Dejan Nikolić
DLDavid C. Lankin
David C. Lankin
GPGuido F. Pauli
Guido F. Pauli

4 January 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ESEkaterina Spirova
Ekaterina Spirova
IIIgor A. Ivanov
Igor A. Ivanov
IKIgor E. Kasheverov
Igor E. Kasheverov
Denis S. KudryavtsevDenis S. Kudryavtsev
Denis S. Kudryavtsev
ISIrina Shelukhina
Irina Shelukhina
VTVictor Tsetlin
Victor Tsetlin
Several novel bisbenzylisoquinoline alkaloids (BBIQAs) have recently been isolated from a Matis tribe arrow poison and shown by two-electrode voltage-clamp to inhibit mouse muscle nicotinic acetylcholine receptors (nAChR). Here, using radioligand assay with Aplysia californica AChBP and radioiodinated α-bungarotoxin ([125I]-αBgt), we show that BBIQA1, BBIQA2, and d-tubocurarine (d-TC) have similar affinities to nAChR orthosteric site. However, a competition with [125I]-αBgt for binding to the Torpedo californica muscle-type nAChR revealed that BBIQAs1, 2, and 3 are less potent (IC50s = 26.3, 8.75, and 17.0 μM) than d-TC (IC50 = 0.39 μM), while with α7 nAChR in GH4C1 cells, BBIQA1 was less potent that d-TC (IC50s = 162 μM and 7.77 μM, respectively), but BBIQA2 was similar (IC50 = 5.52 μM). In inhibiting the Ca2+ responses induced by acetylcholine in Neuro2a cells expressing the mouse adult α1β1εδ nAChR or human α7 nAChR, BBIQAs1 and 2 had similar potencies to d-TC (IC50s in the range 0.75–3.08 μM). Our data suggest that BBIQA1 and BBIQA2 can inhibit adult muscle α1β1εδ nAChR by both competitive and noncompetitive mechanisms. Further experiments on neuronal α3β2, α4β2, and α9α10 nAChRs, expressed in Xenopus laevis oocytes, showed that similar potencies for BBIQAs1, 2, and d-TC. With α3β2γ2 GABAAR currents were almost completely inhibited by d-TC at a high (100 μM) concentration, but BBIQAs1 and 2 were less potent (only 40–50% inhibition), whereas in competition with Alexa Fluor 546-α-cobratoxin for binding to α1β3γ2 GABAAR in Neuro2a cells, d-TC and these analogs had comparable affinities. Especially interesting effects of BBIQAs1 and 2 in comparison with d-TC were observed for 5-HT3AR: BBIQA1 and BBIQA2 were 5- and 87-fold less potent than d-TC (IC50 = 22.63 nM). Thus, our results reveal that these BBIQAs differ from d-TC in their potencies towards certain Cys-loop receptors, and we suggest that understanding the reasons behind this might be useful for future drug design.

6 December 2010 in Arkivoc
Verified
Journal Article
Open access
LHLothar Hennig
Lothar Hennig
GGGonzalo Rodolfo Malca Garcia
Gonzalo Rodolfo Malca Garcia
AGAthanassios Giannis
Athanassios Giannis
Rainer W BussmannRainer W Bussmann
Rainer W Bussmann